Article Details
Retrieved on: 2024-09-08 17:45:15
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes RG-6237, a Roche drug in development, highlighting GlobalData's business intelligence tools. It links fundamental analysis, valuation models like rNPV (Risk-Adjusted Net Present Value), and decision-making in capital budgeting and investment processes.
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here